SCHEMBL12476366

SCHEMBL12476366

Cc1cccc2c(Cl)ncc(C(=O)O)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAVCR2 Q8TDQ0 1/20 0.46
KDM4E B2RXH2 6/20 0.43
LMNA P02545 3/20 0.43
HTT P42858 1/20 0.43
MYC P01106 1/20 0.42
HPGD P15428 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 3/20 0.42
LDHA P00338 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
RAB9A P51151 2/20 0.40
KDM4A O75164 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
HIF1AN Q9NWT6 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12476951 0.83 KDM4E (0.47) HAVCR2KDM4ELMNAHTTMYC
SCHEMBL12697387 0.80 POLB (0.45) KDM4ELMNAHTTALDH1A1SMN1; SMN2
SCHEMBL12475971 0.79 HTT (0.50) LMNAHTTHPGDALDH1A1TP53
SCHEMBL12697435 0.79 CNR2 (0.48) LMNAHTTHPGDALDH1A1NPC1
SCHEMBL12476286 0.79 KDM4E (0.44) HAVCR2KDM4ELMNAHTTMYC
SCHEMBL12697356 0.78 CNR2 (0.49) KDM4ELMNAHTTHPGDALDH1A1
SCHEMBL7494879 0.78 HAVCR2 (0.52) HAVCR2KDM4ELMNAHTTMYC
SCHEMBL12697384 0.76 PLAUR (0.53) KDM4ELMNAHTTHPGDALDH1A1
SCHEMBL12476297 0.76 HCRTR1 (0.42) HPGD
SCHEMBL12476298 0.76 CNR2 (0.39) LMNAHTTHPGDALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006442-B2 Cannabinoid receptor modulators LUPIN LIMITED (IN) 2015-04-14 US disclosed
US-20130178457-A1 CANNABINOID RECEPTOR MODULATORS LUPIN LIMITED (IN) 2013-07-11 US disclosed
WO-2013005168-A2 CANNABINOID RECEPTOR MODULATORS LUPIN LIMITED (IN) 2013-01-10 WO disclosed
WO-2012090177-A2 CANNABINOID RECEPTOR MODULATORS LUPIN LIMITED (IN) 2012-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178457-A1 CANNABINOID RECEPTOR MODULATORS CNR1, CNR2, GPR18 HAVCR2 1627/4885KDM4E 3238/4885LMNA 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.